Kamada to participate at the PPTA’s 2013 Plasma Protein Forum

People worldwide rely on access to plasma-derived and recombinant analog therapies to improve and save their lives, and this is an opportunity for all stakeholders to come together. Consumers, physicians, caregivers, regulators and policymakers, and industry representatives should attend. Key issues facing the industry today and in the future will be presented.